Abstract
Aims: Acute neutropenia induced by antibiotics is a rare side effect of this frequently prescribed class of drugs. We aim to find similarities and differences between reported cases. Methods: Through a database search (PubMed, 1968–2020), we identified published case reports and extracted, among other data, patient demographics, duration of treatment with the respective agent, and duration of recovery. Results: Overall, 83 cases were included. Neutropenia developed after a median (min–max) of 21 (17.5–28.5) days of treatment and was resolved after a median (min–max) of 6 (3.0–8.75) days. Vancomycin and ceftaroline emerged as the two most commonly described antibiotics. In 51.8% of cases, the suspected antibiotic was discontinued; in 37.4% of cases, it was substituted by another agent. Only three case reports mentioned death as a result of neutropenia. The use of granulocyte colony-stimulating growth factors (CSFs) shortened the duration of neutropenia and improved outcome for patients' health. Conclusion: Neutropenia induced by antibiotics remains a rare or rarely reported side effect. Long-term and high-dose treatment regimens expose a higher risk of development. Thus, regular full blood counts are advised during therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 1978-1984 |
| Number of pages | 7 |
| Journal | British Journal of Clinical Pharmacology |
| Volume | 88 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - May 2022 |
Keywords*
- agranulocytosis
- antibiotics
- drug-induced
- neutropenia
- side effect
Field of Science*
- 3.2 Clinical medicine
- 3.1 Basic medicine
Publication Type*
- 1.1. Scientific article indexed in Web of Science and/or Scopus database
Fingerprint
Dive into the research topics of 'Acute antibiotically induced neutropenia: A systematic review of case reports'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver